Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Early hair loss may indicate prostate issues.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Plant-based ingredients in hair care are being replaced by synthetic alternatives.

Western diet may cause male pattern baldness; low glycemic diet with magnesium could help.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

The review suggests a comprehensive approach to treat hirsutism, focusing on hair removal, medication, and managing emotional effects.

Women with idiopathic hirsutism and PCOS have higher RBP4 levels, and PCOS is linked to greater insulin resistance; weight management may help both conditions.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Benign ovarian tumors can cause excess male hormones and related conditions in postmenopausal women.

Flutamide caused damage to male rat reproductive organs and may affect fertility.

Men with male pattern baldness may have a higher risk of heart disease due to increased levels of a specific lipid in their blood.

The document suggests that Alopecia X in dogs is mainly a cosmetic issue and might be better left untreated.

Children receive less than half of recommended health care, and routine hormonal testing for female-pattern hair loss is unnecessary without other androgen excess symptoms.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Finasteride effectively treats BPH, but needs more trials to understand potential.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Guidelines for diagnosing common hair loss include detailed history, clinical examination, and various diagnostic techniques.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

Lowering testosterone speeds up wound healing in male mice.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.